139 related articles for article (PubMed ID: 12872691)
1. [Effectiveness of oseltamivir on influenza and influencing factors: age of patients, type of influenza virus and timing of initial administration].
Kawai N; Iwaki N; Kawashima T; Satoh I; Tsuchimoto T; Shigematsu T; Kondoh K; Maeda T; Hirotsu N; Kunishima O; Kashiwagi S
Kansenshogaku Zasshi; 2003 Jun; 77(6):423-9. PubMed ID: 12872691
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.
Kawai N; Ikematsu H; Iwaki N; Satoh I; Kawashima T; Maeda T; Miyachi K; Hirotsu N; Shigematsu T; Kashiwagi S
Clin Infect Dis; 2005 May; 40(9):1309-16. PubMed ID: 15825034
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.
Kawai N; Ikematsu H; Iwaki N; Maeda T; Satoh I; Hirotsu N; Kashiwagi S
Clin Infect Dis; 2006 Aug; 43(4):439-44. PubMed ID: 16838232
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.
Treanor JJ; Hayden FG; Vrooman PS; Barbarash R; Bettis R; Riff D; Singh S; Kinnersley N; Ward P; Mills RG
JAMA; 2000 Feb; 283(8):1016-24. PubMed ID: 10697061
[TBL] [Abstract][Full Text] [Related]
5. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
6. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment.
Gillissen A; Höffken G
Med Microbiol Immunol; 2002 Dec; 191(3-4):165-8. PubMed ID: 12458353
[TBL] [Abstract][Full Text] [Related]
7. Experience with oseltamivir in the control of nursing home influenza A outbreak.
Shijubo N; Yamada G; Takahashi M; Tokunoh T; Suzuki T; Abe S
Intern Med; 2002 May; 41(5):366-70. PubMed ID: 12058885
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.
Mawatari M; Saito R; Hibino A; Kondo H; Yagami R; Odagiri T; Tanabe I; Shobugawa Y;
PLoS One; 2019; 14(11):e0224683. PubMed ID: 31697721
[TBL] [Abstract][Full Text] [Related]
9. Neuraminidase inhibitors: zanamivir and oseltamivir.
McNicholl IR; McNicholl JJ
Ann Pharmacother; 2001 Jan; 35(1):57-70. PubMed ID: 11197587
[TBL] [Abstract][Full Text] [Related]
10. Oseltamivir: a review of its use in influenza.
McClellan K; Perry CM
Drugs; 2001; 61(2):263-83. PubMed ID: 11270942
[TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of oseltamivir treatment against influenza type A and type B infection in children].
Mitamura K; Sugaya N; Nirasawa M; Shinjoh M; Takeuchi Y
Kansenshogaku Zasshi; 2002 Nov; 76(11):946-52. PubMed ID: 12508478
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized, placebo-controlled multicenter study of oseltamivir phosphate for treatment of influenza infection in China.
Li L; Cai B; Wang M; Zhu Y
Chin Med J (Engl); 2003 Jan; 116(1):44-8. PubMed ID: 12667386
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.
Cooper NJ; Sutton AJ; Abrams KR; Wailoo A; Turner D; Nicholson KG
BMJ; 2003 Jun; 326(7401):1235. PubMed ID: 12791735
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.
Nicholson KG; Aoki FY; Osterhaus AD; Trottier S; Carewicz O; Mercier CH; Rode A; Kinnersley N; Ward P
Lancet; 2000 May; 355(9218):1845-50. PubMed ID: 10866439
[TBL] [Abstract][Full Text] [Related]
16. [A multicenter study of efficacy and safety of oseltamivir in treatment of naturally acquired influenza].
Li L; Cai B; Wang M; Zhu Y
Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):838-42. PubMed ID: 16206676
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.
Welliver R; Monto AS; Carewicz O; Schatteman E; Hassman M; Hedrick J; Jackson HC; Huson L; Ward P; Oxford JS;
JAMA; 2001 Feb; 285(6):748-54. PubMed ID: 11176912
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children.
Oo C; Barrett J; Hill G; Mann J; Dorr A; Dutkowski R; Ward P
Paediatr Drugs; 2001; 3(3):229-36. PubMed ID: 11310719
[TBL] [Abstract][Full Text] [Related]
19. [Ergoferon and oseltamivir in treatment of influenza: results of multicentre randomized comparative clinical trial].
Aver'ianov AV; Babkin AP; Bart BIa; Volchetskiĭ AL; Minina ES; Kozyrev OA; Kostinov MP; Petrov DV; Sel'kova EP; Putilovskiĭ MA; Nechaev VB; Epshteĭn OI; Andrianova EN
Antibiot Khimioter; 2012; 57(7-8):23-30. PubMed ID: 23350191
[TBL] [Abstract][Full Text] [Related]
20. [Neuraminidase inhibitor].
Kaji M
Nihon Rinsho; 2000 Nov; 58(11):2293-8. PubMed ID: 11225320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
